:: Library Catalog

Buchumschlag

Gespeichert in:

Bibliographische Detailangaben
1. Verfasser:	Pål O. Westermark
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2025
Schlagworte:	Statistics in Medicine
Online-Zugang:	https://onlinelibrary.wiley.com/doi/10.1002/sim.70044
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Response to the Commentary on “Experimental Design and Power Calculation in Omics Circadian Rhythmicity Detection Using the Cosinor Model”
von: RuoFei Yin, et al.
Veröffentlicht: (2025)

Authors' Response to Comments by Di Tanna et al.
von: Heejung Bang, et al.
Veröffentlicht: (2026)

Weighted Trigonometric Regression for Suboptimal Designs in Circadian Transcriptome Studies
von: Michael T. Gorczyca, et al.
Veröffentlicht: (2025)

Sample Size Calculation for the ROCI Design
von: Henry Bern, et al.
Veröffentlicht: (2026)

Integrating Multiple Data Sources With Interactions in Multi‐Omics Using Cooperative Learning
von: Matteo D'Alessandro, et al.
Veröffentlicht: (2025)

Sample Size and Power Calculations With Win Measures Based on Hierarchical Endpoints
von: Huiman Barnhart, et al.
Veröffentlicht: (2025)

A Causal Perspective on “Appropriate Implementation of ICH E9 ( R1 ) Addendum Strategies” (Comment on Fleming et al.)
von: Tim P. Morris, et al.
Veröffentlicht: (2026)

Sample Size Calculation in Dose Optimization Trials Using the Margin of Practical Non‐Inferiority
von: Hakim‐Moulay Dehbi, et al.
Veröffentlicht: (2025)

Comments on “Novel Non‐Linear Models for Clinical Trial Analysis With Longitudinal Data: A Tutorial Using SAS for Both Frequentist and Bayesian Methods”
von: M. C. Donohue, et al.
Veröffentlicht: (2025)

Comments on “Sample Size Adaptation Designs and Efficiency Comparison With Group Sequential Designs”
von: Meinhard Kieser, et al.
Veröffentlicht: (2025)

Power and Sample Size Calculations for Cluster Randomized Hybrid Type 2 Effectiveness‐Implementation Studies
von: Melody A. Owen, et al.
Veröffentlicht: (2025)

Two‐Stage Drop‐the‐Losers Design for the Selection of Effective Treatments and Estimating Their Average Worth
von: Yogesh Katariya, et al.
Veröffentlicht: (2025)

Instrumental Variable Model Average With Applications in Nonlinear Causal Inference
von: Dong Chen, et al.
Veröffentlicht: (2024)

Integrating Omics and Pathological Imaging Data for Cancer Prognosis via a Deep Neural Network‐Based Cox Model
von: Jingmao Li, et al.
Veröffentlicht: (2026)

Expected Value of Sample Information Calculations for Risk Prediction Model Development
von: Abdollah Safari, et al.
Veröffentlicht: (2026)

Simultaneous Representation Learning of Multi‐Omics and Clinical Outcome Data via a Supervised Knowledge‐Guided Bayesian Factor Model
von: Qiyiwen Zhang, et al.
Veröffentlicht: (2026)

Overcoming Model Uncertainty — How Equivalence Tests Can Benefit From Model Averaging
von: Niklas Hagemann, et al.
Veröffentlicht: (2025)

Integrative Multi‐Omics and Multivariate Longitudinal Data Analysis for Dynamic Risk Estimation in Alzheimer's Disease
von: Yuanyuan Guo, et al.
Veröffentlicht: (2025)

Multivariate Adjustments for Average Equivalence Testing
von: Younes Boulaguiem, et al.
Veröffentlicht: (2025)

Reconciling Binary Replicates: Beyond the Average
von: H. Lorenzo, et al.
Veröffentlicht: (2026)

A Sensitivity Analysis Framework Using the Proxy Pattern–Mixture Model for Generalization of Experimental Results
von: Rebecca R. Andridge, et al.
Veröffentlicht: (2025)

Estimating Average Treatment Effects With Support Vector Machines
von: Alexander Tarr, et al.
Veröffentlicht: (2025)

Response to Letter to the Editor “Comments on ‘Novel Non‐Linear Models for Clinical Trial Analysis With Longitudinal Data: A Tutorial Using SAS for Both Frequentist and Bayesian Methods’”
von: Guoqiao Wang, et al.
Veröffentlicht: (2025)

Matching‐Based Nonparametric Estimation of Group Average Treatment Effects
von: Peng Wu, et al.
Veröffentlicht: (2026)

A Novel Stratified Analysis Method for Testing and Estimating Overall Treatment Effects on Time‐To‐Event Outcomes Using Average Hazard With Survival Weight
von: Zihan Qian, et al.
Veröffentlicht: (2025)

Improved Pharmacovigilance Signal Detection Using Bayesian Generalized Linear Mixed Models
von: Paloma Hauser, et al.
Veröffentlicht: (2025)

Regional Consistency Evaluation and Sample Size Calculation Under Two MRCTs
von: Kunhai Qing, et al.
Veröffentlicht: (2025)

A Model Based on Mixture of Weibull Distributions for Depending Competing Risks Data in the Presence of Long‐Term Survivors, and Its Application to Malignant Melanoma Cancer Data
von: Ayon Ganguly, et al.
Veröffentlicht: (2026)

Identification and Estimation of the Average Causal Effects Under Dietary Substitution Strategies
von: Yu‐Han Chiu, et al.
Veröffentlicht: (2025)

A Bayesian Approach to Estimate Causal Average Treatment Effects Under Unmeasured Confounding
von: Jinghong Zeng
Veröffentlicht: (2026)

A Precision Mixture Risk Model to Identify Adverse Drug Events in Subpopulations Using a Case‐Crossover Design
von: Yi Shi, et al.
Veröffentlicht: (2024)

Bayesian Borrowing With Multiple Heterogeneous Historical Studies Using Order Restricted Normalized Power Prior
von: Zifei Han, et al.
Veröffentlicht: (2025)

Tuning LASSO Models for Propensity Score Weighting and Using Synthetic Negative Control Exposures for Residual Bias Detection
von: Richard Wyss, et al.
Veröffentlicht: (2026)

Commentary on Fleming et al. “A Perspective on the Appropriate Implementation of ICH E9 ( R1 ) Addendum Strategies for Handling Intercurrent Events”
von: Oliver Keene, et al.
Veröffentlicht: (2026)

Dirichlet Distribution Parameter Estimation With Applications in Microbiome Analyses
von: Daniel T. Fuller, et al.
Veröffentlicht: (2026)

Group Sequential Trial Design Using Stepwise Monte Carlo for Increased Flexibility and Robustness
von: Amitay Kamber, et al.
Veröffentlicht: (2025)

Statistical Inference for a Two‐Stage Adaptive Seamless Design Using Different Binary Endpoints
von: Ryota Ishii, et al.
Veröffentlicht: (2025)

Sample Size Re‐Estimation in Blinded Hybrid‐Control Design Using Inverse Probability Weighting
von: Masahiro Kojima, et al.
Veröffentlicht: (2026)

Adaptive Sparsening and Smoothing of the Treatment Model for Longitudinal Causal Inference Using Outcome‐Adaptive LASSO and Marginal Fused LASSO
von: Mireille E. Schnitzer, et al.
Veröffentlicht: (2026)

On Inclusion of Covariates in Model Based Dose Finding Clinical Trial Designs
von: Adrien Ollier, et al.
Veröffentlicht: (2025)